Healthcare -
Biotechnology - NASDAQ - US
$ 4.125
-2.6 %
$ 1.35 B
Market Cap
-3.22
P/E
IOVA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities IOVA - Iovance Biotherapeutics, Inc.
463 M
LAST VALUE
39.10%
2 YEAR CAGR
1.76%
5 YEAR CAGR
34.81%
10 YEAR CAGR